Press release
China Cancer Drugs Market is projected to reach US$ 30 Billion by 2024
china-cancer-drugs-market-therapy-companies
https://www.renub.com/china-cancer-drugs-market-p.php
Get Free Customization in This Report
As per Renub Research analysis Anti-Cancer drugs are the drugs which are used to reduce or prevent the cell proliferation of cancerous tissues. China Cancer Drugs Market is projected to reach US$ 30 Billion by the year 2024; owing to the increasing prevalence of various types of cancer, changing lifestyle & dietary habits, growing aging population, rising demand of targeted drug therapy and the patent expiration of key cancer drugs. Cancer is one of the leading causes of death worldwide and is a major public health burden in both developed and developing countries.
The rate of cancer incidences in China is exploding very rapidly; nearly 4 million people diagnosed and almost 3 million died from it. For instance; due to increasing air pollution over the last couple of years, lung cancer has increased 50% in Beijing only. Anticancer drugs act like an inhibitor that prevents cancer cells to grow.
In addition; factors like growing awareness regarding cancer diagnosis & treatment, advancement in cancer drugs and therapies, rise in cancer awareness programs like breast cancer screening, investment in healthcare infrastructure are expected to drive China anti-cancer drugs market positively over the forecast period. However, major side-effects of cancer drugs and its high cost are certainly restraining the China anti-cancer drugs market to reach its full potential.
Request a free sample copy of the report: https://www.renub.com/contactus.php
Renub Research report titled “China Cancer Drugs Market, by Drugs [Cytotoxic Drugs (Antimetabolities, Plant Alkaloids, Alkylating Agents), Targeted Drugs, Monoclonal Antibiotics, Hormonal Drugs, Traditional Chinese Medicine (TCM), & Others], Cancer (Lung, Stomach, Breast, Esophageal, Liver & Others), Therapy (Chemotherapy, Targeted Therapy, Hormonal Therapy & Others), Companies (Merck, Celgene, Eli Lilly, Roche & Sino BioPharma)” provides a complete analysis of China Anti-Cancer Drugs Market.
By Drugs – Cytotoxic Drugs leads the Cancer Drugs Market in China
Based on the drugs type, China cancer drugs market is segmented into cytotoxic drugs, targeted drugs, Monoclonal Antibiotics, hormonal drugs, TCM and Others. The cytotoxic drugs segment is further classified into Antimetabolites, Plant Alkaloids and Alkylating Agents.
By Cancer – Lungs Cancer accounts for the largest share of China Cancer Drugs Market
On the basis of cancer type, China cancer drugs market is segmented into Lung, Stomach, Breast, Esophageal, Liver & Others. Lung, Breast and Stomach Cancer dominates the China anti-cancer drugs market and is expected to do so in the near future.
By Therapy – Targeted Therapy is expected to grow significantly during the forecast period
By therapy type, the China anti-cancer drugs market is segmented into chemotherapy, targeted therapy, hormonal therapy and others. Chemotherapy and targeted therapy together held the major share of China cancer drugs market.
Company Analysis
Some of the prominent companies competing in the China Anti-Cancer Drugs Market, and profiled in the report include Merck, Celegene, Eli Lilly, Roche and Sino BioPharma.
This market research report provides a complete analysis of the China Cancer Drugs Market, Growth Drivers, Challenges, and their projections for the upcoming years.
By Drugs
• Cytotoxic Drugs
o Antimetabolities
o Plant Alkaloids
o Alkylating Agents
• Targeted Drugs
• Monoclonal Antibiotics
• Hormonal Drugs
• Traditional Chinese Medicine (TCM)
• Others
By Cancer
• Lung Cancer
• Stomach Cancer
• Breast Cancer
• Esophageal Cancer
• Liver Cancer
• Others
By Therapy
• Chemotherapy
• Targeted Therapy
• Hormonal Therapy
• Others
Companies Covered in the Report
• Merck
• Celegene
• Eli Lilly
• Roche
• Sino BioPharma
Contact Us
Rajat Gupta
Sr. Marketing Manager
Email: info@renub.com
Phone: +1-678-302-0700
Web: www.renub.com
Renub Research is a leading Market Research and Information Analysis Company with centers at Noida India and Roswell USA. We have long-term experience especially in international Business-to-Business Researches, Surveys, Business and Consulting. Throughout the years we have acquired expertise in most market sectors, including Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others.
Our core team is comprised of an experienced people holding graduate, post graduate and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research help make the business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today's ultra-competitive markets.
225 Kristie Ln, Roswell, GA 30076, United States
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release China Cancer Drugs Market is projected to reach US$ 30 Billion by 2024 here
News-ID: 1205781 • Views: …
More Releases from Renub Research
Global TAVR Market to Hit $19.69 Billion by 2033, Driven by Aging Population and …
Transcatheter Heart Valve Replacement Market Overview
The market for transcatheter heart valve replacement (THVR) is expanding significantly due to rising patient demand for minimally invasive treatments and advancements in technology. For patients with high surgical risk, transcatheter aortic valve replacement (TAVR) has emerged as the preferred option over open heart surgery. Globally, TAVR usage is growing, with North America and Europe leading the way in procedure numbers due to their sophisticated…
Global Air Conditioner Market to Reach USD 257.20 Billion by 2032, Driven by Urb …
Air Conditioner Market Analysis
Introduction
From comfort to necessity, air conditioners have become a staple in both residential and commercial spaces around the world. As global temperatures rise and urbanization accelerates, the air conditioner market continues to expand-evolving in design, technology, and energy efficiency.
This in-depth guide explores the global air conditioner market, including growth drivers, consumer trends, technological innovations, challenges, and future projections. Whether you're an investor, manufacturer, retailer, or informed buyer,…
Global Chocolate Market Analysis, Size, Share, Growth ⅼ Forecast (2024 - 2032) …
Global Chocolate Market Size was US$132.65 billion in 2023 and is expected to reach to US$196.79 billion by 2032. It is predicted to expend at a CAGR of 4.48% from 2024 to 2032.
Chocolate is a beloved treat worldwide and has been for hundreds of years. The worldwide chocolate industry is worth billions of dollars, and new trends are continuously emerging. Chocolate liquor and cocoa cream are used to make…
Global Automotive Air Suspension Market, Size, Share, Growth ⅼ Forecast (2024 …
Global Automotive Air Suspension Market value is expected to be about US$ 11.20 Billion by 2032. The CAGR for the automotive air suspension market from 2024 to 2032 is 6.05%. Renub Research stated that it was valued at US$ 6.60 Billion in 2023.
During World War II, the US developed an air suspension system, especially for heavier aircraft. Air suspension was first developed as a lightweight, compact construction method. A vehicle…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
